49
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury

, , , , , & show all
Pages 197-203 | Received 06 Jan 2010, Accepted 03 Feb 2010, Published online: 05 Mar 2010

References

  • Alarie Y. 1985. The toxicity of smoke from polymeric materials during thermal decomposition. Annu Rev Pharmacol Toxicol 25:325–347.
  • Alarie Y, Stock MF, Matijak-Schaper M, Birky MM. 1983. Toxicity of smoke during chair smoldering tests and small scale tests using the same materials. Fundam Appl Toxicol 3:619–626.
  • Barrow RE, Morris SE, Basadre JO, Herndon DN. 1990. Selective permeability changes in the lungs and airways of sheep after toxic smoke inhalation. J Appl Physiol 68:2165–2170.
  • Bidani A, Hawkins HK, Wang CZ, Heming TA. 1999. Dose dependence and time course of smoke inhalation injury in a rabbit model. Lung 177:111–122.
  • Borson DB, Brokaw K, Sekizawa DM, Nadel JA. 1989. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 66:2653–3658.
  • Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
  • Cox RA, Burke, AS, Soejima K, Murakami K, Katahira J, Traber LD, Herndon DN, Schmalstieg FC, Traber DL, Hawkins HK. 2003. Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 29:295–302.
  • Cox RA, Mlcak RP, Chinkes DL. 2008. Upper airway mucus deposition in lung tissue of burn trauma victims. Shock 29:356–361.
  • Crapo RO. 1981. Smoke-inhalation injuries. JAMA 246:1694–1696.
  • Damas V, Bourdon JF, Simmons WH. 1996. Influence of several peptidase inhibitors on the pro-inflammatory effects of substance P, capsaicin and collagenase. Naunyn-Schmiedeberg’s Arch Pharmacol 354:1432–1912.
  • Day AL, Wick E, Jordan TH, Jaffray CE, Bunnett NW, Grady EF, Kirkwood KS. 2005. Neutral endopeptidase determines the severity of pancreatitis-associated lung injury. J Surg Res 128:21–27.
  • Demling RH. 2008. Smoke inhalation lung injury: an update. Eplasty 16; e27.
  • Dost FN. 1991. Acute toxicology of components of vegetation smoke. Rev Environ Contam Toxicol 119:1–46.
  • Dusser DJ, Umeno PD, Graf T, Djokic DB, Borson DB, Nadel JA. 1988. Airway neutral endopeptidase-like enzyme modulates tachykinin induced bronchoconstriction in vivo. J Appl Physiol 65:2585–2591.
  • Enkhbaatar, P, Murakami K, Traber LD, Cox R, Parkinson JF, Westphal M, Esechie A, Morita N, Maybauer MO, Maybauer DM, Burke AS, Schmalstieg FC, Hawkins HK, Herndon DN, Traber DL. 2006. The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 25:522–527.
  • Enkhbaatar P, Traber DL. 2004. Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 107:137–143.
  • Harrison S, Geppetti P. (2000). Substance P. Int J. Biochem. Cell Biol 33:555–516.
  • Hon YL, Madhav B. 2006. The effect of CP96, 345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis. J Pathol 208:364–371.
  • Jacob S, Deyo DJ, Cox RA, Traber DL, Hawkins HK. 2008. Assessment of lung inflammation in a mouse model of smoke inhalation and burn injury: strain-specific differences. Toxicol Mech Meth 18:1–9.
  • Jacob S, Deyo DJ, Cox RA, Traber DL, Herndon DN, Hawkins HK. 2009. Mechanisms of toxic smoke inhalation and burn injury: role of neutral endopeptidase and vascular leakage in mice. Toxicol Mech Methods 19:191–196.
  • Johnson AR, Ashthon J, Scypinski L, Dusser D, Nadel J, Borson D. 1985. Toluene diisothiocynate increases airway responsiveness to substance P and decreases airway neutral endopeptidase in human lung tissue and cultured cells. Am Rev Resp Dis 132:564–568.
  • Kuo JA, Rohde K, Tokuyama PJ, Barnes PJ, Rodgers DF. 1990. Capsaicin and sensory neuropeptides stimulation of goblet cell secretion in guinea pig trachea. J Appl Physiol 431:629–641.
  • LaLonde C, Nayak U, Hennigan J, Demling R. 1996. Antioxidants prevent the cellular deficit produced in response to burn injury. J Burn Care Rehabil 17:379–383.
  • Lau HY, Bhatia M. 2006. The effect of CP96345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis. J Pathol 208:364–371.
  • Linares HA. 1981. A report of 115 consecutive autopsies in burned children: 1966–80. Burns 8:263–270.
  • Lowe JA, III, Drozda SE, Snider RM, Longo KP, Zorn SH, Jackson ER, Morrone J, McLean S, Bryce DK, Bordner J. 1993. Discovery of CP-96345 and its characterization in disease models involving substance P. Regul Pept 46:20–23.
  • Lundberg JM, Brodin E, Hua X, Saria A. 1984. Vascular permeability changes and smooth muscle contraction in relation to substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand 119:243–252.
  • Martins MA, Shore SA, Gerard NP, Gerard C, Drazen JM. 1990. Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs. J Clin Invest 85:170–176.
  • McDonald DM, Bowden JJ, Baluk P, Bunnett NW. 1996. Neurogenic inflammation. A model for studying efferent actions of sensory nerves. Adv Exp Med Biol 1996;410:453–462.
  • Nadel JA. 1991. Neutral endopeptidase modulates neurogeic inflammation. Euro Respir J 4:745–754.
  • Nicolau M, Dovichi SS, Cuttle G. 2003. Pro-inflammatory effect of quercetin by dual blockade of angiotensin converting-enzyme and neutral endopeptidase in vivo. Nutr Neurosci 6:309–316.
  • Pham D, Jeng AY, Escher E, Sirois P, Battistini B. 2000. Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats. J Cardiovasc Pharmacol 36(5 Suppl 1):S362–S366.
  • Prien T, Traber DL. 1988. Toxic smoke compounds and inhalation injury—a review. Burns Incl Therm Inj 14:451–460.
  • Pryor WA. 1992. Biological effects of cigarette smoke, wood smoke, and the smoke from plastics: the use of electron spin resonance. Free Radic Biol Med 13:659–676.
  • Richardson JD, Vasko MR. 2002. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302:839–845.
  • Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A. 1993. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87–146.
  • Sakurai H, Johnigan R, Kikuchi Y, Harada M, Traber LD, Traber DL. 1998. Effect of reduced bronchial circulation on lung fluid flux after smoke inhalation in sheep. J Appl Physiol 84:980–986.
  • Shirani KZ, Moylan JA, Pruitt BA Jr. 1987. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 205:82–87.
  • Shore SA, Drazen JM. 1991. Relative bronchoconstrictor activity of neurokinin A and neurokinin A fragments in the guinea pig. J Appl Physiol 71:452–457.
  • Sio SW, Puthia MK, Lu J, Moochhala S, Bhatia M. 2008. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury. J Immunol 180:8333–8341.
  • Snider RM, Constantine JW, Lowe JA III, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess HJ. 1991. Effect of CP-96345, a nonpeptide substancce P receptor antagonist, on salivation in rats. Science 251:435–437.
  • Stephenson SF, Esrig BC, Polk HC, Fulton RL. 1975. The pathophysiology of smoke inhalation injury. Ann Surg 182:652–660.
  • Stimler-Gerard NP. 1987. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J Clin Invest 79:1819–1825.
  • Tanaka DT, Grunstein MM. 1986. Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol 60:458–463.
  • Traber DL, Hawkins HK, Enkhbaatar P, Cox RA, Schmalstieg FC, Zwischenberger JB, Traber LD. 2007. The role of bronchial circulation in the acute lung injury resulting from brun and smoke inhalation. Pulm Pharmacol Ther 20:163–166.
  • Traber DL, Herndon DN. 1990. Pathophysiology of smoke inhalation. In: Haponik EF, Munster AM, editors. Respiratory injury. New York: McGraw-Hill. pp 61–71.
  • Traber DL, Herndon DN. 1991. Pathophysiology of smoke inhalation. In: Haponik EF, Munster AM, editors. Respiratory injury: Smoke inhalation and burns. New York: McGraw-Hill. pp 61–71.
  • Vinggaard AM, Nielsen GD, Fries AS. 1989. Sensory and pulmonary irritation of inhaled n-butylamine in CF-1 and NMRI mice. Lab Anim 23:1–6.
  • Wang LF, Patel M, Razavi HM, Weicker S, Joseph MG, McCormack DG, Mehta S. 2002. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 165:1634–1639.
  • Westphal M, Cox RA, Traber LD, Morita, N, Enkhbaatar P, Schmalstieg FC, Hawkins HK, Maybauer DM, Maybauer MO, Murakami K, Burke AS, Westphal-Varghese BB, Rudloff HE, Salsbury JR, Jodoin JM, Lee S, Traber DL. 2006. Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med 34:1428–1436.
  • Wong SS, Sun NN, Keith I, Kweon CB, Foster DE, Schauer JJ, Witten ML. 2003. Tachykinin substance P signaling involved in diesel exhaust-induced bronchopulmonary neurogenic inflammation in rats. Arch Toxicol 77:638–650.
  • Wong SS, Sun NN, Lantz RC, Witten ML. 2004. Substance P and neutral endopeptidase in development of acute respiratory distress syndrome following fire smoke inhalation. Am J Physiol Lung Cell Mol Physiol 287:L859–L866.
  • Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, Kron IL, Laubach VE. 2006. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 291:L1018–L1026.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.